LX-2761
Product Detail
Product Tags
| Pack Size | Availability | Pretium (USD) |
| 100mg | In Stock | 500 |
| 500mg | In Stock | 800 |
| 1g | In Stock | 1200 |
| Plus Sizes | Get Quotes | Get Quotes |
Nomen chemicum:
N-((2-(2-(Dimethylamino)ethyl)amino)-2-methyl-1-oxopropan-2-yl)-4-(4-(2-methyl-5-((2S,3R,4R; 5S,6R)-3,4,5-trihydroxy-6-(methylthio) tetrahydro-2H-pyran-2-yl)benzyl)phenyl)-butanamide
SMILES Code:
O=C(NC(C)(C)C(NCCN(C)C)=O)CCCC1=CC=C(CC2=CC([C@H]3[C@H](O)[C@@ H](O)[C@H](O)[C@@H](SC)O3)=CC=C2C)C=C1
InChi Code:
InChI=1S/C32H47N3O6S/c1-20-10-15-23(29-27(38)26(37)28(39)30(41-29)42-6)19-24(20) 18-22- 13-11-21(12-14-22)8-7-9-25(36)3 . 4-32(2,3)31(40)33-16-17-35(4)5/h10-15,19,26-30,37-39H,7-9,16-18H2,1-6H3; (H,33,40)(H,34,36)/t26-,27-,28+,29+,30-/m1/s1
InChi Key:
BNPZTRDIESRGTC-IXYVTWBDSA-N
Keyword:
LX-2761, LX2761, LX 2761, 1610954-97-6 .
Solubilitas:Solutum in DMSO
Repono:0 - 4°C ad terminum brevem (dies ad septimanas), vel -20°C ad terminum longi (menses).
Descriptio:
LX2761 localiter agens GLT1 inhibitor, qui in vitro et moras glucosi intestinalis effusio in vivo ad imperium glycemicum emendandum plurimum valet. LX2761 habet hSGLt1 2.2 nM; hSGLT2 2.7 nM et F% =<2. LX2761 validissima, chemica stabilis, moleculae luminaliter restricta, quae conceptus in OGTT dosibus infimis probationem consecutus est. LX2761 destinatum est ut in intestino remanere post partum oralem inhibere GLT1 localiter sine afficiens mechanismum GLT1/2 in renibus.
Target: SGLT1
